S
TGTX icon

SignatureFD’s TG Therapeutics TGTX Stock Holding History

SignatureFD’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
372
+213
+134% +$8.72K ﹤0.01% 2335
2026
Q1 		$5.28K Buy
159
+124
+354% +$3.69K ﹤0.01% 2760
2025
Q4 		$1.04K Buy
35
+1
+3% +$33 ﹤0.01% 3112
2025
Q3 		$1.23K Sell
34
-14
-29% -$461 ﹤0.01% 3047
2025
Q2 		$1.73K Buy
48
+13
+37% +$484 ﹤0.01% 2910
2025
Q1 		$1.38K Sell
35
-41
-54% -$1.38K ﹤0.01% 2973
2024
Q4 		$2.29K Buy
76
+44
+138% +$1.26K ﹤0.01% 2832
2024
Q3 		$748 Buy
32
+6
+23% +$131 ﹤0.01% 3044
2024
Q2 		$463 Sell
26
-52
-67% -$830 ﹤0.01% 2992
2024
Q1 		$1.19K Buy
+78
New +$1.24K ﹤0.01% 2923
2022
Q2 		– Sell
-532
Closed -$5K – 3343
2022
Q1 		$5K Buy
532
+187
+54% +$2.16K ﹤0.01% 2515
2021
Q4 		$7K Sell
345
-2
-0.6% -$52 ﹤0.01% 2291
2021
Q3 		$12K Buy
347
+21
+6% +$650 ﹤0.01% 1989
2021
Q2 		$13K Sell
326
-67
-17% -$2.63K ﹤0.01% 1904
2021
Q1 		$19K Buy
393
+80
+26% +$3.84K ﹤0.01% 1596
2020
Q4 		$16K Hold
313
– – ﹤0.01% 1535
2020
Q3 		$8K Hold
313
– – ﹤0.01% 1744
2020
Q2 		$6K Buy
313
+50
+19% +$805 ﹤0.01% 1755
2020
Q1 		$3K Buy
+263
New +$3.32K ﹤0.01% 1861

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

SignatureFD's TGTX Position: Q2 2026 in Review

SignatureFD increased its TG Therapeutics (TGTX) stake by 134% in Q2 2026, buying an estimated $8.72K and bringing the position to 372 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

SignatureFD first reported a position in TGTX in Q1 2020 and has held it in 19 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • SignatureFD held 372 shares of TG Therapeutics worth $20.4K as of Q2 2026.
  • SignatureFD bought 213 TG Therapeutics shares in Q2 2026, an estimated $8.72K.
  • TG Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2335 holding.
  • SignatureFD first reported a position in TG Therapeutics in Q1 2020 and has held it in 19 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.